近接治療設備市場 - 成長，趨勢，預測
Brachytherapy Devices Market - Growth, Trends, and Forecast (2020 - 2025)
|出版商||Mordor Intelligence LLP||商品編碼||922040|
|出版日期||內容資訊||英文 111 Pages
|近接治療設備市場 - 成長，趨勢，預測 Brachytherapy Devices Market - Growth, Trends, and Forecast (2020 - 2025)|
|出版日期: 2020年01月01日||內容資訊: 英文 111 Pages||
Brachytherapy devices are commonly used for effectively treating gynecologic, prostate, breast, and other types of cancer. According to the World Health Organization (WHO), cancer is the second leading cause of death globally and was estimated to account for 9.6 million death in 2018. Brachytherapy is related to the implementation of radioactivity within the body, to ablate or kill cancer or tumor cells within, or near the target area in the body. It is also used in combination with chemotherapy, surgery or external radiation therapy. Other factors, such as rising government initiatives to increase awareness and technological advancements in minimally invasive surgical procedures is expected to drive the brachytherapy devices market in the forecast period.
However, the lack of skilled radiologists and advanced radiotherapy facilities and reimbursement issues is among the major barrier to the growth of this market over the forecast period.
As per the scope of the report, Brachytherapy is a type of internal radiation therapy that involves the placement of radioactive material inside the patient body to treat cancer.
Breast Cancer Segment is Expected to Register a Significant Growth Over the Forecast Period
By Application, the market has been segmented into gynecologic cancer, prostate cancer, breast cancer, and others. The breast cancer segment is expected to register significant growth as compared to other cancer types. This is majorly attributed to the increasing prevalence of breast cancer across the world. As per estimates provided by the Breast Cancer Organization in 2019, an estimated 268,600 new cases of invasive breast cancer are expected to be diagnosed in women in the United States, along with 62,930 new cases of non-invasive (in situ) breast and this is expected to grow during the forecast period. Intracavitary brachytherapy is the most common type of brachytherapy for women with breast cancer. In this approach, a device containing radioactive substance is placed within the body and is left there until treatment is complete. In addition, rising government initiatives to increase awareness and technological advancements in minimally invasive surgical procedures also contribute to the growth of the brachytherapy devices market.
North America Dominates the Market and Expected to do the Same Over the Forecast Period
North America dominates the market owing to the increasing incidences of cancer and early adoption of new technologies. The United States holds the majority of the market in the North American region due to high patient pool and well-developed infrastructure. However, Asia Pacific is expected to grow at a faster rate due to the increasing awareness regarding advanced treatment options, and the presence of emerging economies in this region. The emerging countries such as India and China are majorly focusing to improve their healthcare infrastructure in both urban and rural areas, which will boost the overall healthcare facility in the region.
The major players in the brachytherapy devices market include Argon Medical Devices, Becton, Dickinson and Company, Carl Zeiss Meditec AG, Eckert & Ziegler BEBIG S.A., Elekta AB, iCAD Inc., Isoray Inc., Theragenics Corporation, and Varian Medical Systems Inc., which provides these products across the globe.